Clinical Trial

Determination of Blomia Tropicalis Allergen Extract in Prick Test Units

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 2, 2025 (before its estimated January 2026 completion). Its status may not reflect the trial's current state.
Summary
The primary objective is to assess the concentration of Blomia tropicalis allergenic extract that induces a wheal of size equivalent to that produced by a 10 mg/mL histamine dihydrochloride solution, in order to be used as in-house reference preparation (IHRP).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-19.
Trial Details
NCT Number NCT07195929
Lead Sponsor Inmunotek S.L.
Conditions Allergic Reactions, Allergic Skin Reaction
Enrollment 30 participants
Start Date 2025-11
Primary Completion 2026-01 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2025-10-02